From the Department of Health Services Research, Management, and Policy (AGM, RJT) and Department of Community Health and Family Medicine, (AGM, PJC, KL), University of Florida, Gainesville, FL; Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA (MMH); Department of Pediatrics and Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA (JB, TDC).
J Am Board Fam Med. 2018 Sep-Oct;31(5):812-816. doi: 10.3122/jabfm.2018.05.180106.
Although most patients with rare diseases like sickle cell disease (SCD) are treated in the primary care setting, primary care physicians may find it challenging to keep abreast of medication improvements and complications associated with treatment for rare and complex diseases. The purpose of this study was to evaluate the effectiveness of a clinical decision support (CDS) -based intervention system for transfusional iron overload in adults with SCD to improve management in primary care.
An electronic medical record based clinical decision support system for potential transfusional iron overload in SCD patients in primary care was evaluated. The intervention was implemented in 3 family medicine clinics with a control group of 3 general internal medicine clinics. Data were collected in the 6 months before the intervention and 6 months after the intervention. There were 47 patients in the family medicine group and 24 in the general internal medicine group.
There was no management change in the control group while the intervention group improved primary care management from 0% to 44% ( < .001).
A CDS tool can improve management of SCD patients in primary care.
尽管大多数患有镰状细胞病(SCD)等罕见疾病的患者在初级保健环境中接受治疗,但初级保健医生可能会发现,要跟上治疗罕见和复杂疾病的药物改进和相关并发症的步伐颇具挑战性。本研究旨在评估一种基于临床决策支持(CDS)的干预系统在治疗 SCD 成人输血性铁过载方面的有效性,以改善初级保健中的管理。
评估了一种基于电子病历的用于初级保健中 SCD 患者潜在输血性铁过载的临床决策支持系统。该干预措施在 3 家家庭医学诊所和 3 家普通内科诊所的对照组中实施。数据在干预前 6 个月和干预后 6 个月收集。家庭医学组有 47 名患者,普通内科组有 24 名患者。
对照组的管理没有变化,而干预组将初级保健管理从 0%提高到 44%(<0.001)。
CDS 工具可以改善初级保健中 SCD 患者的管理。